Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT05816499 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV
NSCLC Stage IIIB
NSCLC Stage IIIC

Interventions

DRUG: Cadonilimab
DRUG: Anlotinib
DRUG: Docetaxel

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]
[object Object]
[object Object]